Research programme: anti-NaPi2b antibody drug conjugates - Araris Biotech
Latest Information Update: 21 May 2024
At a glance
- Originator Araris Biotech
- Class Antibodies; Antineoplastics; Drug conjugates; Immunoconjugates; Peptides
- Mechanism of Action DNA topoisomerase I inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer